Linezolid oral suspension and preparation method thereof

A technology of oral suspension and linezolid, which is applied in the fields of pharmaceutical formulation, liquid delivery, emulsion delivery, etc., can solve the problems of inconvenient clinical medication, long process cycle, slow disintegration and slow curative effect, and achieve good physical and chemical compatibility effect

Active Publication Date: 2019-02-22
CHONGQING HUAPONT PHARMA
View PDF9 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, there is still the problem that children need to give linezolid according to body weight and it is difficult to divide the dose; in addition, even if the orally disintegrating tablet of the present invention is fast, it needs to go through the process of disintegrating in a solid state and then dispersing to exert its drug effect. Compared with liquid preparations, its Disintegration and efficacy are still slow
In addition, the present invention uses freeze-drying method to prepare tablets, which requires special freeze-drying equipment, long and complicated process cycle, and high manufacturing cost. The main drug specification of linezolid itself is relatively large. For example, the main drug specification of the marketed oral tablet is 0.6g. The high cost of raw materials, coupled with high manufacturing costs, will inevitably increase the financial burden on patients
[0014] Due to the characteristics of carrying large-capacity injections, inconvenient clinical medication, poor patient compliance, and difficult or inaccurate dosage of oral solid preparations, it is currently necessary to develop a preparation that is convenient to take, easy to divide and accurate in dosage

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Linezolid oral suspension and preparation method thereof
  • Linezolid oral suspension and preparation method thereof
  • Linezolid oral suspension and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0068] Embodiment 1 Linezolid Oral Suspension Formula 1 and Preparation Method

[0069] (1) Preparation prescription: (made 1000ml in total)

[0070]

[0071] (2) Preparation method:

[0072] 1) Weigh 4 / 5 of the prescription amount of purified water, add the prescription amount of suspending agent sodium carboxymethyl cellulose to it, heat to 80-100°C, stir to swell and clarify, and cool to room temperature to obtain solution I;

[0073] 2) Add the wetting agent polysorbate 80 to solution I, stir to dissolve, and obtain solution II;

[0074] 3) Add linezolid micropowder to solution II, disperse at 5000 rpm for 5 minutes, mix well, and flocculate to obtain suspension III;

[0075] 4) adding pH regulator sodium citrate and citric acid to suspension III to obtain suspension IV;

[0076] 5) Finally, add the prescribed amount of preservative sodium benzoate, sweetener sorbitol, and flavoring agent cherry powder essence to the suspension IV, stir at 30 Hz for 10 minutes, after...

Embodiment 2

[0077] Embodiment 2 Linezolid Oral Suspension Formula 2 and Preparation Method

[0078] (1) Preparation prescription: (made 1000ml in total)

[0079]

[0080] (2) Preparation method:

[0081] 1) Weigh 4 / 5 of the prescription amount of purified water, add the prescription amount of suspending agent sodium carboxymethyl cellulose to it, heat to 80-100°C, stir to swell and clarify, and cool to room temperature to obtain solution I;

[0082] 2) Add the wetting agent polysorbate 80 to solution I, stir to dissolve, and obtain solution II;

[0083] 3) Add linezolid micropowder to solution II, disperse at 5000 rpm for 8 minutes, mix well, and flocculate to obtain suspension III;

[0084] 4) adding pH regulator sodium citrate and citric acid to suspension III to obtain suspension IV;

[0085] 5) Finally, add the prescribed amount of preservative sodium benzoate, sweetener sorbitol, and flavoring agent cherry powder essence to the suspension IV, stir at 30 Hz for 10 minutes, after...

Embodiment 3

[0086] Example 3 Linezolid Oral Suspension Formula 3 and Preparation Method

[0087] (1) Preparation prescription: (made 1000ml in total)

[0088]

[0089]

[0090] (2) Preparation method:

[0091] 1) Weigh 4 / 5 of the prescription amount of purified water, add the prescription amount of suspending agent sodium carboxymethyl cellulose to it, heat to 80-100°C, stir to swell and clarify, and cool to room temperature to obtain solution I;

[0092] 2) Add the wetting agent polysorbate 80 to solution I, stir to dissolve, and obtain solution II;

[0093] 3) Add linezolid micropowder to solution II, disperse at 5000 rpm for 8 minutes, mix well, and flocculate to obtain suspension III;

[0094] 4) adding pH regulator sodium citrate and citric acid to suspension III to obtain suspension IV;

[0095] 5) Finally, add the prescribed amount of preservative sodium benzoate, sweetener sorbitol, and flavoring agent cherry powder essence to the suspension IV, stir at 30 Hz for 10 minut...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
particle sizeaaaaaaaaaa
particle sizeaaaaaaaaaa
particle sizeaaaaaaaaaa
Login to view more

Abstract

The invention belongs to the field of pharmaceutic preparation, and specifically a linezolid oral suspension and a preparation method thereof. The linezolid oral suspension comprises the following components by weight: 0.5-2.0 parts of linezolid, 0.5-5.0 parts of sodium carboxymethyl cellulose, 0.05-0.5 part of polysorbate 80, 0.15-0.20 part of sodium citrate, 0.08-0.10 part of citric acid, 0.22-0.28 part of a preservative, 22-28 parts of sweetener, 1.2-1.8 parts of a correctant and an aqueous medium. The present invention fills the market blank of only containing tablet or injection, and provides a novel dosage form choice. The linezolid oral suspension product has good quality, can be accurately divided into the dosage based on body weight, and is easy to swallow. The preparation process is simple, feasible and reproducible, and can consistently produce linezolid oral suspension with quality meeting the requirements.

Description

technical field [0001] The invention belongs to the field of pharmaceutical preparations, in particular to a linezolid oral suspension and a preparation method thereof. Background technique [0002] Linezolid is the first new type of antibiotic that has been approved for marketing among oxazolidinone compounds. It was developed by Upjohn Company. In 2000, the FDA approved its marketing for the treatment of Gram-positive (G+) cocci. Infection, including suspected or confirmed hospital-acquired pneumonia (HAP), community-acquired pneumonia (CAP), complicated skin or skin and soft tissue infection (SSTI), and vancomycin-resistant enterococcus (VRE) infection caused by MRSA. [0003] Linezolid is a bacterial protein synthesis inhibitor that acts on the bacterial 50S ribosomal subunit and is closest to the site of action. Unlike other drugs, linezolid does not affect the activity of peptidyl transferase, but only acts on the initial stage of the translation system, inhibits the ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): A61K9/10A61K31/5377A61K47/38A61K47/12A61K47/10A61K47/26A61P31/04
CPCA61K9/0053A61K9/10A61K31/5377A61K47/12A61K47/26A61K47/38
Inventor 徐飞
Owner CHONGQING HUAPONT PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap